| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
13636370518 |
| Email: |
shyysw007@163.com |
| Products Intro: |
Product Name:Tiragolumab (anti-TIGIT)
CAS:1918185-84-8
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:5mg Remarks:K10636
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Tiragolumab
CAS:1918185-84-8
Purity:95% Package:100ug;500ug;1mg
|
Tiragolumab manufacturers
- Tiragolumab
-
- $147.00
-
2026-05-21
- CAS:1918185-84-8
- Purity: 98.8% (SEC-HPLC)
- Supply Ability: 10g
|
| | Tiragolumab Basic information |
| Product Name: | Tiragolumab | | Synonyms: | Tiragolumab;Research Grade Tiragolumab(DHH72401);Tiragolumab (anti-TIGIT);RO 7092284|||RG6058-10|||MTIG-7192A|||RG6058-11|||RG-6058;Research Grade Tiragolumab | | CAS: | 1918185-84-8 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Tiragolumab Structure]() |
| | Tiragolumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Tiragolumab Usage And Synthesis |
| Description | Tiragolumab is a monoclonal antibody that targets the inhibitory receptor T-cell immunoglobulin and ITIM domain (TIGIT), which is expressed on lymphocytes and suppresses the immune response to cancer. | | Uses | Tiragolumab is an investigational novel immune checkpoint inhibitor with an intact Fc region and is thought to work as an immune amplifier with other cancer immunotherapies, based on preclinical research. |
| | Tiragolumab Preparation Products And Raw materials |
|